Loading organizations...
The Accelerate Blue Fund is an early-stage venture fund dedicated to investing exclusively in startups licensed from the University of Michigan. It provides crucial seed capital and support to companies commercializing innovations developed within the university, focusing on bridging the funding gap for nascent ventures. This strategic approach ensures that groundbreaking research finds pathways to market.
Established and managed by Innovation Partnerships at the University of Michigan, the fund emerged from the insight that a dedicated capital source was needed to nurture university-spawned intellectual property. This initiative leverages the university's research strengths, creating a structured mechanism to convert academic discoveries into viable commercial enterprises and supporting the entrepreneurial ecosystem within the institution.
The fund's primary beneficiaries are University of Michigan-licensed startups, which rely on its early investment to scale their operations and develop their technologies. Accelerate Blue Fund’s long-term vision is to foster the successful commercialization of U-M innovations, driving economic impact and bringing novel solutions to a broader audience by cultivating a robust pipeline of high-potential companies.
Accelerate Blue Fund has 2 tracked investments across 2 companies. The latest tracked deal is $23.0M Series B in Movellus in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 20, 2022 | Movellus | $23.0M Series B | — | Candou Ventures, HUI Capital, IN Q TEL, Intel Capital, Edward Chyau, Michigan Capital Network, Heejin Chung, Stata Venture Partners |
| Sep 1, 2022 | Arcascope | $3.0M Seed | Supermoon Capital | AIoT Health, HealthX Ventures, Inception Health, Inflect Health, Monroe Brown Seed Fund, NEW Dominion Angels |